One monoclonal antibody treatment used at many U.S. hospitals

Name: One monoclonal antibody treatment used at many U.S. hospitals
Uploaded: 2022-01-26T23:00:53Z
Duration: 2 min 8 s
Description: The FDA has pulled emergency use authorization for Regeneron and Eli Lilly's antibody drugs, saying they did not work against the Omicron variant, leaving Sotrovimab as the only monoclonal treatment being used at many hospitals across the nation.

The FDA has pulled emergency use authorization for Regeneron and Eli Lilly's antibody drugs, saying they did not work against the Omicron variant, leaving Sotrovimab as the only monoclonal treatment being used at many hospitals across the nation.

Posted January 26, 2022 6:00pm EST